保妇康栓联合中药治疗宫颈高危型HPV感染的疗效观察

详细信息    查看全文 | 推荐本文 |

英文篇名：Therapeutic effect of Baofukang suppository combined with traditional Chinese medicine on cervical high-risk HPV infection 作者：梁翠霞 ; 贺小薇 ; 李杏婵 英文作者：LIANG Cuixia;HE Xiaowei;LI Xingchan;Department of Obstetrics and Gynecology,Tangxia Hospital of Guangdong;Department of Ultrasound,Tangxia Hospital of Guangdong; 关键词：保妇康栓 ; 人乳头状瘤病素感染 ; 宫颈癌 ; 中药治疗 英文关键词：Baofukang Suppository;;Human papillomavirus Infection;;Cervical cancer;;Chinese medicine treatment 中文刊名：GYKX 英文刊名：China Medicine and Pharmacy 机构：广东省东莞市塘厦医院妇产科;广东省东莞市塘厦医院超声科; 出版日期：2019-01-15 出版单位：中国医药科学 年：2019 期：v.9;No.193 基金：广东省中医药局科研项目(20161261) 语种：中文; 页：GYKX201901021 页数：4 CN：01 ISSN：11-6006/R 分类号：79-81+182

摘要

目的重点分析保妇康栓联合中药治疗宫颈高危型HPV(人乳头瘤病毒)感染的疗效。方法从我院妇科门诊选择120例患者作为本次研究的对象,将其随机分为对照组与观察组,对照组仅进行观察不做治疗,观察组则采用保妇康栓联合中药进行治疗。对比分析两组的临床治疗效果。结果观察组的临床治疗效果(90.000%)明显比对照组(71.667%)高,且差异有统计学意义(P <0.05);观察组的HPV转阴率明显高于对照组,且差异有统计学意义(P <0.05)。结论将保妇康栓联合中药用于治疗宫颈高危型HPV感染,可在一定程度上提高HPV转阴率,从而提高了患者临床治疗效果。
        Objective To analyze the efficacy of Baofukang suppository combined with traditional Chinese medicine in the treatment of cervical high-risk HPV(HPV) infection. Methods One hundred and twenty patients were selected from the gynaecology department of our hospital as subjects of this study,and they were randomly divided into control group and observation group.The control group was observed and not treated,The observation group was treated with Baofukang suppository combined with traditional Chinese medicine.The clinical treatment effects of the two groups were compared and analyzed. Results The clinical treatment effect of the observation group(90.000%) was significantly higher than that of the control group(71.667%),and the difference was statistically significant(P < 0.05).The HPV conversion rate of the observation group was significantly higher than that of the control group,and the difference was statistically significant(P < 0.05).Conclusion The combination of Baofukang suppository and traditional Chinese medicine for the treatment of high-risk HPV infection of the cervix can improve the conversion rate of HPV to a certain extent,thus improving the clinical treatment effect of patients.

引文

[1]吴立芳,韩松云,沈灵,等.LEEP联合保妇康栓治疗宫CIN伴高危型HPV感染的临床观察[J].哈尔滨医药,2014,34(3):218-219.
    [2]曹清丽,唐超君,谢秀萍.LEEP术后联用保妇康栓对宫颈上皮内瘤变I级伴高危型人乳头瘤病毒持续性感染的临床研究[J].岭南急诊医学杂志,2016,21(4):395-397.
    [3]施丽娜.鱼腥草联合保妇康栓治疗合并高危型HPV感染的CINⅠ及宫颈炎的临床观察[J].中国现代医生,2013,51(16):128-129.
    [4]支雄莉,陈海霞,胡志君,等.保妇康栓联合派特灵治疗HR-HPV感染的疗效比较[J].河北医药,2016,38(16):2468-2470.
    [5]叶银利,桑晓庆,熊翡,等.中药联合保妇康栓治疗宫颈高危型HPV感染及CINⅠ的临床观察[J].浙江中医杂志,2015,50(7):478-479.
    [6]殷秀莲,陈娟娟.克林霉素注射液联合保妇康栓对慢性宫颈炎伴高危型人乳头瘤病毒感染患者的疗效分析[J].药物评价研究,2017(2):225-228.
    [7]许彩芹,李艳华,李颖敏,等.保妇康栓和干扰素联合中药治疗低度宫颈上皮内瘤变合并高危型HPV感染的疗效观察[J].中国妇幼保健,2017,32(20):4932-4934.
    [8]潘丽,庞丽萍,张久存,等.银芨散联合认知疗法治疗宫颈高危型HPV感染的临床研究[J].中国妇幼保健,2016,31(3):660-662.
    [9]林碧英.臭氧联合保妇康栓治疗286例宫颈上皮内瘤变合并高危型人乳头瘤病毒感染的疗效观察[J].上海医药,2017,38(11):26-28.
    [10]孟钊,薛素华,张凌.宫颈环形电切术联合保妇康栓治疗高危型HPV感染宫颈上皮内瘤变224例[J].中医研究,2015,28(3):12-14.
    [11]秦锦龙,付铭旭,成佳景.中药配合保妇康治疗宫颈高危型人乳头状瘤病毒感染疗效观察[J].现代中西医结合杂志,2016,25(14):1538-1540.
    [12]徐美玉.膦甲酸钠氯化钠联合保妇康栓治疗高危型HPV感染宫颈炎的临床研究[J].实用临床医药杂志,2015,19(21):174-175.
    [13]吴艳,郑定容.妊娠期女性HPV感染基因型及临床治疗[J].中外医学研究,2017,15(5):15-17.
    [14]郭菲菲,南蓓蓓.高危型HPV感染与宫颈病变的关系[J].中国当代医药,2017,24(3):86-88,100.
    [15]刘红梅,黄雪玉,刘小艳,等.重组人干扰素α2b凝胶联合保妇康栓治疗宫颈高危型HPV感染的疗效观察[J].广东医学院学报,2016,34(3):312-313.
    [16]张红,付晓丽,蔡翠霞,等.保妇康栓联合中药治疗宫颈HPV感染临床疗效观察[J].内蒙古中医药,2017(15):81.
    [17]戴星,周静,邹志雄,等.保妇康栓联合辛复宁治疗宫颈高危型人乳头瘤病毒感染的疗效分析[J].中国中医药现代远程教育,2015,13(24):62-63.